Stock THER THERALINK TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Market Closed - OTC Markets
Other stock markets
 03:50:24 2024-05-13 pm EDT 		5-day change 1st Jan Change
0.0006 USD 0.00% Intraday chart for Theralink Technologies, Inc. -14.29% -60.00%
May. 06 Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction. CI
Feb. 20 Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Theralink Technologies, Inc. Announces Chief Executive Officer Changes
CI
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer
CI
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary
CI
Theralink Technologies Appoints Michael Vallone as Senior Director of Commercialization
CI
Theralink Technologies, Inc. Appoints Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company
CI
Theralink Technologies, Inc. Appoints Mattia Cremona as Its Director of Its Biopharma Laboratory
CI
Theralink Technologies, Inc. Announces Board Appointments
CI
OncBioMune Pharmaceuticals, Inc. has Changed its Name to Theralink Technologies, Inc
CI
OncBioMune Pharmaceuticals, Inc. Appoints Andrew Kucharchuk as Acting Chief Financial Officer
CI
OncBioMune Pharmaceuticals, Inc. Announces Executive Changes
CI
OncBioMune Pharmaceuticals, Inc. Announces Management Changes
CI
OncBioMune Pharmaceuticals, Inc. Announces Resignation of Andrew Kucharchuk as Chief Financial Officer
CI
OncBioMune Pharmaceuticals, Inc. Appoints Andrew Kucharchuk as Director
CI
OncBioMune Pharmaceuticals Appoints Mitesh J. board as Scientific Advisory Board
CI
OncBioMune Pharmaceuticals, Inc. Announces Management Changes
CI
OncBioMune Pharmaceuticals, Inc. Appoints Robert Neal Holcomb to Board of Directors
CI
Manuel Cosme Odabachian Resigns as Member of the Board of Directors of OncBioMune Pharmaceuticals, Inc
CI
OncBioMune Pharmaceuticals, Inc. Announces Executive Changes
CI
Anuel Cosme Odabachian to Join OncBioMune Pharmaceuticals as an executive officer
CI
OncBioMune Pharmaceuticals, Inc. Appoints Brian Barnett to its Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THER Stock
  4. News Theralink Technologies, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW